Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Arovella Therapeutics Limited ABN/ARBN Financial year ended: 35 090 987 250 30 June...